October 28, 2022
Continuing treatment with two common multiple sclerosis (MS) medications during pregnancy is associated with significantly lower relapse rates and few pregnancy-related complications, new research shows. Results […]
October 28, 2022
Falls are common in patients with multiple sclerosis (MS) and a new study suggests impairment in a specific aspect of neuromuscular function can identify those at […]
October 27, 2022
Rates of subarachnoid hemorrhage (SAH) are increasing, particularly in Black people, new research suggests. Results of a new study based on hospital discharge data show Black […]
October 27, 2022
Patients with relapsing-remitting multiple sclerosis (MS) treated with autologous hematopoietic stem cell transplantation (AHSCT) were 74% more likely than those taking fingolimod (Gilenya) to be relapse-free […]
October 27, 2022
Cardiorespiratory fitness protects against declines in gait quality in patients with multiple sclerosis (MS), new research shows. Investigators found that over time, lower cardiorespiratory fitness predicts […]
October 27, 2022
Hot flashes and night sweats in middle-aged women are associated with greater white matter hyperintensity volume (WMHV), a marker of small vessel disease in the brain, […]
October 26, 2022
“We eat first with our eyes.” The Roman foodie Apicius is thought to have uttered those words in the 1st century AD. Now, some 2,000 years […]
October 26, 2022
A novel approach to repetitive transcranial magnetic stimulation (rTMS) that targets the precuneus appears to slow the progression of cognitive and functional decline in patients with […]
October 24, 2022
Less than 5% of people whose opioid therapy is managed in a pain management setting test positive for illicit drugs, a new study found. An analysis […]